<!DOCTYPE html>
<html lang="en">
<head>
    <title>REDARK | MAKE DATA FOR RARE DISEASES</title>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="description" content="HTML5 website template">
  <meta name="keywords" content="global, template, html, sass, jquery">
  <meta name="author" content="Bucky Maler">
  <link rel="icon" href="assets/img/logo.png" type="image/x-icon">
  <link rel="stylesheet" href="assets/css/main.css">
  <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.5.1/css/all.min.css">
    <style>
        /* Full-page animated background */
        body {
            margin: 0;
            padding: 0;
            height: 100vh;
            overflow: hidden;
            display: flex;
            justify-content: center;
            align-items: center;
            background: linear-gradient(45deg, #ff0000, red, darkred, #ff0000);
            animation: gradientAnimation 10s ease infinite;
            font-family: 'Vazir', sans-serif;
            overflow: scroll; 
        }

        @keyframes gradientAnimation {
            0% { background-position: 0% 50%; }
            50% { background-position: 100% 50%; }
            100% { background-position: 0% 50%; }
        }

        .black-box {
            background: rgba(0, 0, 0, 0.9);
            border-radius: 15px;
            padding: 30px;
            box-shadow: 0 8px 30px rgba(0, 0, 0, 0.5);
            width: 90%;
            margin-top: 300px;
            max-width: 1200px;
        }

        .table-title {
            color: white;
            font-size: 20px;
            text-align: right;
            margin-bottom: 25px;
            border-bottom: 1px solid rgba(255,255,255,0.2);
            padding-bottom: 10px;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            color: white;
        }

        th, td {
            padding: 14px;
            text-align: center;
            border: 1px solid #444;
        }

        th {
            background: rgba(255, 255, 255, 0.05);
            font-weight: 600;
        }

        tr:hover td {
            background: rgba(255, 255, 255, 0.1);
        }

        th:first-child,
        td:first-child {
            text-align: right;
            width: 35%;
        }

        .feature-column {
            color: #ff4444;
            font-weight: 500;
        }
        .price-row {
            background: rgba(255, 255, 255, 0.03);
        }

        .price-row td {
            border: none;
            padding: 20px;
            font-size: 14px;
        }        .hint {
            font-size: 12px;
            color: #aaa;
            margin-top: 20px;
            text-align: left;
        }
        p{
            color:white;
        }
    </style>
</head>
<body>
    <div class="black-box">
       <p><p>
ðŸ“„ Technical Summary: Synthetic DMD Dataset<br>
Version 2.1 | Ordibehesht 1404<br><br>

1. Overview<br>
This synthetic dataset simulates populations of patients with Duchenne Muscular Dystrophy (DMD), generated using advanced epidemiological models and realistic genetic distributions.<br><br>

2. Key Specifications<br>
Parameter: Patient Population, Value: 1,500,000<br>
Parameter: Time Span, Value: 2005-2024<br>
Parameter: Average Visits/Patient, Value: ~18 (Â±4.5)<br>
Parameter: Clinical Variables, Value: 52<br>
Parameter: Covered Mutations, Value: 7 types (Exon45-50 Del: 32%, Exon2-10 Dup: 17%, Exon51-55 Del: 13%, Nonsense: 11%, Frameshift: 9%, Splice_Site: 8%, Other: 10%)<br><br>

3. Methodology<br>
Disease Progression Modeling:<br>
- Non-linear trajectories based on modified differential equations<br>
- Steroid effects modeled via dose-response PK/PD relationships<br><br>

Data Generation:<br>
- Statistical distributions (Weibull for diagnosis delay, Lognormal for CK levels)<br>
- Realistic noise injection (Â±15% for physiological parameters)<br><br>

4. Applications<br>
- Clinical trial cohort design<br>
- Predictive model training for disease progression<br>
- Long-term treatment outcome simulations<br><br>

5. Compliance<br>
- Ethical: Fully synthetic (no identifiable patient data)<br>
- Regulatory: Compliant with GDPR, HIPAA, and FDA 21 CFR Part 11<br><br>

ðŸ“Š Validation Report (Summary)<br>

1. Real-World Data Correlation<br>
Parameter: Annual FVC Decline, Accuracy (Concordance): 93.4% Â± 1.8%, Validation Source: Real-world clinical databases<br>
Parameter: Baseline CK Levels, Accuracy (Concordance): 87.9% Â± 2.3%, Validation Source: Multicenter DMD registries<br>
Parameter: Wheelchair Dependency Age, Accuracy (Concordance): 89.1% Â± 3.1%, Validation Source: Independent longitudinal studies<br><br>

2. Predictive Performance<br>
Outcome: Cardiomyopathy, AUC: 0.89, Precision: 85.3%, Validation Source: Cardiac outcome studies<br>
Outcome: Respiratory Failure, AUC: 0.92, Precision: 88.7%, Validation Source: Pulmonary function databases<br><br>

3. Sensitivity Analysis<br>
- Sample Size Impact: Standard error <2% for N > 10,000<br>
- Noise Tolerance: Â±5% outcome variation with Â±15% input noise<br><br>

ðŸ“© Collaboration Inquiry<br>
For sample data access or technical briefings, contact: dmd.datateam@techsynth.com<br><br>

This document is formatted for universal appeal, omitting organization-specific references while maintaining scientific rigor.
</p>

</p>
    <div class="hint">* Features shown represent standardized capabilities - actual implementation includes proprietary algorithms and validation protocols</div>
    </div>
</body>
</html>
